Derek K. Cole
President chez Investor Relations Advisory Solutions LLC
Profil
Derek K.
Cole is currently the Director at Colorado BioScience Association and the President at Investor Relations Advisory Solutions LLC.
Previously, he held positions as the Chairman at National Investor Relations Institute, Director-Investor Relations at Gilead Colorado, Inc., Director at National Investor Relations Institute (Rocky Mountain), Vice President-Investor Relations at Allos Therapeutics, Inc., and Head-Investor Relations & Corporate Communications at Alexza Pharmaceuticals, Inc. He also served as the Investor Relations & Media Contact at ARCA biopharma, Inc. from 2009 to 2012.
Postes actifs de Derek K. Cole
| Sociétés | Poste | Début |
|---|---|---|
Colorado BioScience Association
 Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Directeur/Membre du Conseil | - |
Investor Relations Advisory Solutions LLC
 Investor Relations Advisory Solutions LLC Investment ManagersFinance Investor Relations Advisory Solutions LLC provides investor relations advisory services. The private company is based in Broomfield, CO. | President | - |
Anciens postes connus de Derek K. Cole
| Sociétés | Poste | Fin |
|---|---|---|
| ARCA BIOPHARMA, INC. | Investor Relations Contact | 01/01/2012 |
National Investor Relations Institute (Rocky Mountain)
 National Investor Relations Institute (Rocky Mountain) Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute engages in IR consultants and related services. The company was founded in 1969 and is headquartered in Denver, CO. | Directeur/Membre du Conseil | - |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Président | - |
| ALEXZA PHARMACEUTICALS, INC. | Public Communications Contact | - |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARCA BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
National Investor Relations Institute (Rocky Mountain)
National Investor Relations Institute (Rocky Mountain) Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute engages in IR consultants and related services. The company was founded in 1969 and is headquartered in Denver, CO. | Commercial Services |
Colorado BioScience Association
Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016. | Commercial Services |
Investor Relations Advisory Solutions LLC
Investor Relations Advisory Solutions LLC Investment ManagersFinance Investor Relations Advisory Solutions LLC provides investor relations advisory services. The private company is based in Broomfield, CO. | Finance |
